Factors Explaining the Coincidence of Smoldering Multiple Myeloma and Primary Biliary Cholangitis: A Case Report - Cureus
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
Multiple myeloma - The Lancet
Extramedullary relapse of Immunoglobulin A-kappa myeloma manifesting as plasmacytoma of the pleura without bone marrow involvement and following autologous bone marrow transplant: a case report | Journal of Medical Case Reports
Multiple Myeloma with Biclonal Gammopathy of IgA Kappa Variant: A Case Report | Semantic Scholar
Cureus | Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management
Measuring M-Protein SPEP, UPEP Tests | Int'l Myeloma Fdn
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Light Chain Myeloma: Symptoms, Treatment, Outlook, More
Kappa and Lambda Light Chains - HealthTree for Myeloma
Goals of Therapy for Multiple Myeloma
Frontiers | Daratumumab for the Treatment of Multiple Myeloma
IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma - Boyle - 2014 - Cancer - Wiley Online Library
Frontiers | Case Report: A case of IgD lambda/lambda Multiple Myeloma in patient with acute renal failure and without monoclonal spike in serum electrophoresis
Multiple Myeloma: Diagnosis and Treatment | AAFP
Cancers | Free Full-Text | Multiple Myeloma: Available Therapies and Causes of Drug Resistance
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Multiple myeloma - The Lancet
Extramedullary relapse of Immunoglobulin A-kappa myeloma manifesting as plasmacytoma of the pleura without bone marrow involvement and following autologous bone marrow transplant: a case report | Journal of Medical Case Reports
Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients | Leukemia
Overview of Multiple Myeloma - CancerConnect
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
UNDERSTANDING MULTIPLE MYELOMA AND LABORATORY VALUES
Management of multiple myeloma
Q413 – 459: Multiple Myeloma / Plasma Cell Disorder - Forms Instruction Manual - 1
Getting the Most Out of Your Treatment: Your Role in Achieving Desired Outcomes in the Patient Journey - CONQUER: the patient voice
Living With - HealthTree for Myeloma
Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials | PLOS ONE
